在小鼠、灌注人眼前节及小梁网细胞中抑制SPARC的效果
研究探讨抑制富含半胱氨酸的酸性分泌蛋白(SPARC)能否降低眼压。用慢病毒短发夹RNA抑制小鼠眼和灌注的尸体人眼前节中的SPARC后,眼压约下降20%,并伴有JCT细胞外基质结构蛋白的定性改变;小梁网细胞中胶原I、IV、纤连蛋白、MMP-2和TIMP-1蛋白减少,PAI-1上调,MMP-1活性降低,但相关基因mRNA未变。
要点
- 抑制SPARC使小鼠眼和灌注人眼前节的眼压下降约20%。
- 小鼠小梁网和人JCT区胶原I、IV、VI减少,小鼠纤连蛋白减少而人未见减少。
- 小梁网细胞中胶原I、IV、纤连蛋白、MMP-2和TIMP-1蛋白减少,PAI-1上调,MMP-1活性降低,mRNA未变。
核心结论
- 抑制SPARC降低了小鼠和灌注尸体人眼前节的眼压,对应JCT细胞外基质的定性结构改变,这些改变似乎不是转录调控的结果。
研究设计与样本
- 研究使用含人SPARC短发夹RNA的慢病毒抑制小鼠眼和灌注的尸体人眼前节中的SPARC并测量眼压,用免疫组化确定结构改变,并在人小梁网细胞培养中采用定量逆转录聚合酶链反应、免疫印迹和酶谱法检测RNA、蛋白水平和MMP酶活性。
主要发现
- 抑制SPARC使小鼠眼和灌注人眼前节的眼压下降约20%。
- 组织学上,小鼠小梁网和人JCT区胶原I、IV、VI减少;小鼠纤连蛋白也减少,但人未见减少。
- 小梁网细胞中胶原I和IV、纤连蛋白、MMP-2和TIMP-1减少,上述基因的mRNA未变。
- 体外定量PCR和免疫印迹显示PAI-1上调,酶谱法显示MMP-1活性降低。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Secreted protein, acidic and rich in cysteine (SPARC) elevates intraocular pressure (IOP), increases certain structural extracellular matrix (ECM) proteins in the juxtacanalicular trabecular meshwork (JCT), and decreases matrix metalloproteinase (MMP) protein levels in trabecular meshwork (TM) endothelial cells. We investigated SPARC as a potential target for lowering IOP. We hypothesized that suppressing SPARC will decrease IOP, decrease structural JCT ECM proteins, and alter the levels of MMPs and/or their inhibitors. METHODS: A lentivirus containing short hairpin RNA of human SPARC suppressed SPARC in mouse eyes and perfused cadaveric human anterior segments with subsequent IOP measurements. Immunohistochemistry determined structural correlates. Human TM cell cultures were treated with SPARC suppressing lentivirus. Quantitative reverse transcriptase polymerase chain reaction (PCR), immunoblotting, and zymography determined total RNA, relative protein levels, and MMP enzymatic activity, respectively. RESULTS: Suppressing SPARC decreased IOP in mouse eyes and perfused human anterior segments by approximately 20%. Histologically, this correlated to a decrease in collagen I, IV, and VI in both the mouse TM and human JCT regions; in the mouse, fibronectin was also decreased but not in the human. In TM cells, collagen I and IV, fibronectin, MMP-2, and tissue inhibitor of MMP-1 were decreased. Messenger RNA of the aforementioned genes was not changed. Plasminogen activator inhibitor 1 (PAI-1) was upregulated in vitro by quantitative PCR and immunoblotting. MMP-1 activity was reduced in vitro by zymography. CONCLUSIONS: Suppressing SPARC decreased IOP in mice and perfused cadaveric human anterior segments corresponding to qualitative structural changes in the JCT ECM, which do not appear to be the result of transcription regulation.
引用
- MacDonald WW, Swaminathan SS, Heo JY, et al. Effect of SPARC Suppression in Mice, Perfused Human Anterior Segments, and Trabecular Meshwork Cells. Invest Ophthalmol Vis Sci. 2022. PMID: 35671048. doi:10.1167/iovs.63.6.8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。